About

IgA nephropathy is a kidney disease where the immune system causes inflammation in the kidney's filtering units, and it can also harm other organs like the liver and skin. Povetacicept is an experimental drug designed to block specific immune signals involved in the disease process. By targeting this pathway, the drug may reduce damaging inflammation in the kidneys and slow the progression of organ damage.